Gadekærets Dyreklinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 7.1% 8.1% 10.3% 8.8%  
Credit score (0-100)  0 34 29 23 27  
Credit rating  N/A BBB BB BB BB  
Credit limit (kDKK)  0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -50.9 830 1,455 1,784  
EBITDA  0.0 -73.5 -42.8 77.6 422  
EBIT  0.0 -90.4 -123 -8.9 330  
Pre-tax profit (PTP)  0.0 -109.4 -175.3 -78.9 274.0  
Net earnings  0.0 -85.3 -199.4 -1.7 211.1  
Pre-tax profit without non-rec. items  0.0 -109 -175 -78.9 274  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 420 357 372 279  
Shareholders equity total  0.0 -45.3 -245 -246 -35.3  
Interest-bearing liabilities  0.0 734 551 435 338  
Balance sheet total (assets)  0.0 770 675 826 829  

Net Debt  0.0 729 546 430 239  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -50.9 830 1,455 1,784  
Gross profit growth  0.0% 0.0% 0.0% 75.4% 22.6%  
Employees  0 1 3 4 4  
Employee growth %  0.0% 0.0% 200.0% 33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 770 675 826 829  
Balance sheet change%  0.0% 0.0% -12.3% 22.3% 0.4%  
Added value  0.0 -73.5 -42.8 71.4 422.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 403 -143 -72 -186  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 1.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 177.7% -14.8% -0.6% 18.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -10.8% -14.0% -0.9% 34.0%  
ROI %  0.0% -9.2% -16.2% -1.8% 85.2%  
ROE %  0.0% -11.1% -27.6% -0.2% 25.5%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% -5.6% -26.6% -23.0% -4.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -991.6% -1,276.0% 554.0% 56.7%  
Gearing %  0.0% -1,619.2% -225.0% -176.7% -959.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 5.8% 8.3% 14.2% 14.3%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.5 0.2 0.2 0.4  
Current Ratio  0.0 0.9 0.4 0.5 0.7  
Cash and cash equivalent  0.0 5.6 4.7 5.6 98.9  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -36.8 -353.6 -454.1 -247.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -73 -14 18 106  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -73 -14 19 106  
EBIT / employee  0 -90 -41 -2 82  
Net earnings / employee  0 -85 -66 -0 53